<h1>India Withdraws Customs Duty Exemptions on 76 Drugs; Reinstates for Three, Including Life-Saving Medications.</h1> The Indian government withdrew exemptions on customs duties for 76 specified drugs, including life-saving ones, to support domestic manufacturers. This decision, effective from February 28, 2016, was made after consultations with various stakeholders. A committee was formed to assess the impact of this withdrawal on drug prices and availability. Based on the committee's recommendations, exemptions were reinstated for three specific drugs: Octreotide, Somatropin, and Anti-Haemophilic factor concentrate VIII IX. This adjustment was announced by a government official in a written response to a parliamentary question.